- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on African American Men in Canada
Total 34 results
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)Completed
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)Completed
-
University of British ColumbiaInternational Council on Amino Acid ScienceCompleted
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)Completed
-
University of British ColumbiaCanadian Cancer Society (CCS); British Columbia Cancer Agency; Athabasca University and other collaboratorsCompletedCancer | Health Behavior | Health Knowledge, Attitudes, Practice | MenCanada
-
University of TorontoCompletedGlycemic Control | Healthy Young Men | Gastrointestinal Hormone ResponseCanada
-
Simon Fraser UniversityCanadian Institutes of Health Research (CIHR); Centre for Hip Health and MobilityCompleted
-
University of CalgaryMovember FoundationCompleted
-
Joan BottorffUniversity of British Columbia; University of Alberta; Newcastle University; Athabasca... and other collaboratorsCompletedMental Health Wellness 1 | Health Behavior | Health Knowledge, Attitudes, Practice | MenCanada
-
BayerCompletedHot Flashes | Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenCanada
-
McMaster UniversityCompletedOverweight and Obesity | Men | WomenCanada
-
Ciusss de L'Est de l'Île de MontréalCHU de Quebec-Universite Laval; Hopital Cité de la SantéRecruitingProstatic Neoplasms | Communication | Psychological Distress | Patient Participation | Adherence, Treatment | Physician-Patient Relations | MenCanada
-
McGill University Health Centre/Research Institute...Canadian Institutes of Health Research (CIHR)RecruitingAging | Osteoporosis | Osteoporotic Fractures | Muscle Loss | Men | Osteoporosis, Age-RelatedCanada
-
Université de SherbrookeActive, not recruitingHypotension | Usual Care | Vasopressors | Mean Arterial Pressure TargetsCanada
-
Novartis PharmaceuticalsCompletedHR+ HER2- Men, Pre/Postmenopausal Advanced Breast CancerCanada
-
Olympus Corporation of the AmericasUnity Health TorontoCompleted
-
University Health Network, TorontoPfizerRecruitingNon-squamous Non-small-cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | ROS1 Gene Rearrangement | MET Activating Mutation | MET AmplificationCanada
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Lymph Nodes | Metastatic Malignant Neoplasm in the Liver | Metastatic Breast Carcinoma | Metastatic Malignant Neoplasm in the Lung and other conditionsUnited States, Canada, Saudi Arabia, Korea, Republic of
-
University of ManitobaVictoria General Hospital FoundationUnknownQuality of Life | Obesity | Exercise | Bariatric Surgery | Roux-En-Y Gastric BypassCanada
-
University Health Network, TorontoNovartis PharmaceuticalsCompletedMyelofibrosis (MF) | Myeloproliferative Neoplasms (MPN) | Polycythemia Vera (PV) | Essential Thrombocythemia (ET)Canada
-
Ottawa Hospital Research InstituteCanadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)... and other collaboratorsCompletedPrimary Myelofibrosis | Venous Thromboembolism (VTE) | Polycythemia Vera (PV) | Essential Thrombocythemia (ET) | JAK2 Mutation | Myeloproliferative Neoplasm (MPN)Canada
-
argenxRecruitingMultifocal Motor Neuropathy (MMN)United Kingdom, Spain, United States, Italy, Netherlands, Germany, France, Belgium, Canada, Poland, Austria
-
AstraZenecaThe Cleveland Clinic; IQVIA RDS Inc.CompletedEligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)United States, Belgium, Italy, Netherlands, Denmark, Taiwan, Poland, Russian Federation, Korea, Republic of, Hungary, United Kingdom, China, New Zealand, Czechia, Australia, South Africa, Ukraine, Japan, Canada, Mexico, Lithuania, Estoni...
-
Incyte CorporationActive, not recruitingMPN (Myeloproliferative Neoplasms)United States, France, United Kingdom, Spain, Canada, Japan, Germany, Switzerland, Belgium, Austria, Italy
-
Boehringer IngelheimCompletedArthroplasty, Replacement | Prevention of Venous Thromboembolism | Moderate Renal Impairment (CrCl 30-50 mL/Min)Austria, Canada, Czechia, Finland, Netherlands, Sweden
-
CelgeneCompletedPrimary Myelofibrosis | MPN-associated MyelofibrosisUnited States, Netherlands, France, Australia, Italy, United Kingdom, Canada, Germany, China, Spain, Belgium, Austria, Poland, Sweden, Japan, Russian Federation
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)Canada, United States, Australia
-
Apollomics Inc.RecruitingGastric Cancer | Pancreatic Cancer | NSCLC | Lung Cancer | Brain Tumor | Glioblastoma Multiforme | Advanced Cancer | Colon Cancer | Solid Tumors | Thyroid Cancer | Renal Cancer | Gastroesophageal Junction Adenocarcinoma | EGFR Gene Mutation | MET Amplification | HGF | MET Alteration | MET Fusion | Exon 14 SkippingUnited States, Spain, France, United Kingdom, Taiwan, Australia, Finland, Italy, Singapore, Hungary, Canada, Puerto Rico, Russian Federation
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast CancerSpain, Czechia, Peru, Russian Federation, Austria, Lithuania, Poland, South Africa, Italy, Ukraine, Israel, Argentina, Belgium, Brazil, France, Hungary, Japan, Latvia, Panama
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Canada, Australia
-
Novartis PharmaceuticalsCompletedMacular Edema (ME)Russian Federation, Turkey, United Kingdom, Belgium, Australia, Hungary, Switzerland, Germany, Italy, Korea, Republic of, Israel, Spain, France, Latvia, Netherlands, Slovakia, Czech Republic, Singapore, Canada
-
Genzyme, a Sanofi CompanyCompletedAlport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2France, Germany, Australia, United States, United Kingdom, Canada
-
CelgeneRecruitingBeta-thalassemia | Myelodysplastic Syndromes (MDS) | Myeloproliferative Neoplasm(MPN)-Associated MyelofibrosisUnited States, Japan, Israel, United Kingdom, Turkey, Greece, France, Australia, Belgium, Bulgaria, Canada, Germany, Italy, Malaysia, Spain, Sweden, Taiwan, Thailand, Tunisia, China, Lebanon, Netherlands
-
Day One Biopharmaceuticals, Inc.RecruitingMelanoma | Colorectal Cancer | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Thyroid Cancer, Papillary | Pilocytic Astrocytoma | Bladder Urothelial Carcinoma | Non-Small Cell Adenocarcinoma | MEK Mutation | RAS Mutation | Pancreatic Acinar Carcinoma | RAF Mutation | CRAF Gene Amplification | RAF1 Gene Amplification and other conditionsUnited States, Canada, Korea, Republic of, Spain, Australia, Belgium, France